The present invention addresses the problem of providing an absorbent article that has an improved ability to transfer menstrual blood from a liquid-permeable layer to an absorbent body and can reduce the amount of the menstrual blood remaining in the liquid-permeable layer. To solve this problem, provided is a sanitary napkin provided with a top sheet, a back sheet and an absorbent body that is interposed between the top sheet and the back sheet, wherein convex portions formed in an excretion orifice contact region of the top sheet are coated with a blood lubricity-imparting agent that has a kinetic viscosity of 0.01-80 mm.sup.2/s at 40° C., a water retention rate of 0.01-4.0 mass % and a weight-average molecular weight of less than 1,000.

Provided are a medical lubricating member including a silicone base material, and a lubricating coated film which is laminated on at least one surface of the silicone base material, in which the silicone base material contains a reactive functional group in the surface on which the lubricating coated film is laminated, and the lubricating coated film is a film formed of a composition containing a hydrophilic polymer and polyisocyanate; a medical device using the medical lubricating member; and a method of producing the medical lubricating member.

A medical device for insertion into a natural or artificial body opening, such as a urinary catheter is described. The medical device comprises a substrate having a wall enclosing an internal cavity that forms a tubular body. The wall extends between a proximal insertion end and a distal rearward end. The wall comprises at least 30 wt % of natural fibers, such as cellulose fibers. One example medical device is, at least to a large extent, made of paper.

A medical assembly is disclosed comprises a stent and a catheter having a balloon, wherein the coefficient of friction and/or the adhesion at the stent/balloon interface are reduced.

A medical device includes a base layer, and a lubrication layer supported on at least a part of the base layer, wherein the lubrication layer contains a block copolymer (A) composed of a first constituting unit derived from a reactive monomer that has an epoxy group and a second constituting unit derived from at least one hydrophilic monomer selected from the group consisting of acrylamide and an acrylamide derivative, and a polymer (B) composed of a constituting unit derived from at least one hydrophilic monomer selected from the group consisting of acrylamide and an acrylamide derivative, wherein the block copolymer (A) is contained in a proportion of 20 to 80% by weight relative to the total weight of the block copolymer (A) and the polymer (B), and wherein the block copolymer (A) is crosslinked or polymerized to form a mesh structure.

An orthopaedic implant can replace a joint in a patient. The orthopaedic implant includes a first component having a first component surface and a second component having a second component surface. The first component surface and the second component surface mate at an interface. The first component surface includes a metal substrate, a nanotextured surface, a ceramic coating, and a transition zone. The nanotextured surface is disposed directly upon the metal substrate and has surface features in a size of 10.sup.−9 meters. The ceramic coating conforms to the nanotextured surface and includes a plurality of bio-active sites configured to attract and retain calcium and phosphorous cations. The transition zone is disposed between the metal substrate and the ceramic coating. The transition zone includes a concentration gradient transitioning from the metal substrate to the ceramic coating and there is no distinct interface between the metal substrate and the ceramic coating.

This disclosure is directed to a resilient interpositional arthroplasty implant for application into a joint to pad cartilage defects, cushion, and replace or restore the articular surface, which may preserve joint integrity, reduce pain and improve function. The implant may endure variable joint compressive and shear forces and cyclic loads. The implant may repair, reconstruct, and regenerate joint anatomy, and thereby improve upon joint replacement alternatives. The walls of this invention may capture, distribute and hold living cells until aggregation and hyaline cartilage regrowth occurs. The implant may be deployed into debrided joint spaces, molding and conforming to surrounding structures with sufficient stability so as to enable immediate limb use after outpatient surgery. Appendages of the implant may repair or reconstruct tendons or ligaments, and menisci by interpositional inflatable or compliant polymer arthroplasties that promote anatomic joint motion.

Ready to use packaged medical products that include hydrated hydrophilic medical devices and methods of making the same.

A surface coating structure of a surgical prosthesis according to an exemplary embodiment of the present disclosure may include: a first coating layer formed on the surface of the surgical prosthesis and including an amino compound for surface adhesion; a second coating layer formed on one side of the first coating layer and including a fluorine compound conferring hydrophobicity to the surface coating structure of the surgical prosthesis; and a third coating layer formed on one side of the second coating layer and including a lubricant component for preventing adhesion of a biomaterial existing in a subject into which the surgical prosthesis is inserted.

The technology relates to a method of producing a moulded polyurethane hydrogel, for example a condom. The method involves forming a solution of at least one polyurethane having a molecular weight of between about 40000 to about 500000 in a water:organic polar solvent comprising less than about 40% (v/v) water; applying a layer of the solution to a mould; drying the layer of the first solution to form a polyurethane film on the mould; and contacting the polyurethane film with a swelling agent under conditions such that the film forms a polyurethane hydrogel with a swelling agent content of between about 1% to about 95%.